Before it can be determined how the orexin system is involved in the mediation of neuropathic pain in a model of SCD, it is important to determine whether factors associated with neuropathic pain (i.e., hyperalgesia) differentially influence orexin neuronal activity. This evidence concerns the gene HCRT and neuropathic pain.